NO164252C - Celledyrkningsmedium og anvendelse derav ved bestemmelse av naerings- og biokjemiske tilstander hos lymfocytter. - Google Patents

Celledyrkningsmedium og anvendelse derav ved bestemmelse av naerings- og biokjemiske tilstander hos lymfocytter.

Info

Publication number
NO164252C
NO164252C NO831985A NO831985A NO164252C NO 164252 C NO164252 C NO 164252C NO 831985 A NO831985 A NO 831985A NO 831985 A NO831985 A NO 831985A NO 164252 C NO164252 C NO 164252C
Authority
NO
Norway
Prior art keywords
lymphocytes
nutritional
determining
cultivation medium
cell cultivation
Prior art date
Application number
NO831985A
Other languages
English (en)
Other versions
NO164252B (no
NO831985L (no
Inventor
William Shive
Original Assignee
Res Dev Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Dev Foundation filed Critical Res Dev Foundation
Publication of NO831985L publication Critical patent/NO831985L/no
Publication of NO164252B publication Critical patent/NO164252B/no
Publication of NO164252C publication Critical patent/NO164252C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO831985A 1982-06-03 1983-06-02 Celledyrkningsmedium og anvendelse derav ved bestemmelse av naerings- og biokjemiske tilstander hos lymfocytter. NO164252C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38482282A 1982-06-03 1982-06-03
US06/492,308 US4499064A (en) 1982-06-03 1983-05-06 Assessment of nutritional status of individuals

Publications (3)

Publication Number Publication Date
NO831985L NO831985L (no) 1983-12-05
NO164252B NO164252B (no) 1990-06-05
NO164252C true NO164252C (no) 1990-09-12

Family

ID=27010775

Family Applications (1)

Application Number Title Priority Date Filing Date
NO831985A NO164252C (no) 1982-06-03 1983-06-02 Celledyrkningsmedium og anvendelse derav ved bestemmelse av naerings- og biokjemiske tilstander hos lymfocytter.

Country Status (18)

Country Link
US (1) US4499064A (no)
EP (1) EP0096560B1 (no)
KR (1) KR890000729B1 (no)
AU (1) AU560934B2 (no)
CA (1) CA1199883A (no)
DE (1) DE3371362D1 (no)
DK (1) DK172418B1 (no)
ES (1) ES522980A0 (no)
FI (1) FI77470C (no)
GB (1) GB2124366B (no)
HK (1) HK90188A (no)
IE (1) IE55162B1 (no)
IL (1) IL68873A (no)
MX (1) MX161244A (no)
NO (1) NO164252C (no)
NZ (1) NZ204471A (no)
PT (1) PT76808A (no)
SG (1) SG57287G (no)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208039A (en) * 1985-12-19 1993-05-04 Centre National De La Recherche Scientifique (Cnrs) Nutrient compositions deprived of methionine and supplemented with homocysteine
GB8900924D0 (en) * 1989-01-17 1989-03-08 Amco Chemie Handel Compositions for use in enzyme deficiencies
US5122469A (en) * 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
US20020032160A1 (en) * 1995-02-24 2002-03-14 Nyce Jonathan W. Compositions & formulations with an epiandrosterone or a ubiquinone & kits & their use for treatment of asthma symptoms & for reducing adenosine/adenosine receptor levels
US5660835A (en) * 1995-02-24 1997-08-26 East Carolina University Method of treating adenosine depletion
US5985665A (en) * 1996-06-19 1999-11-16 Research Development Foundation Biochemical analysis of antioxidant function of lymphocytes in culture
TW517089B (en) 1996-09-03 2003-01-11 Res Dev Foundation Assessment of intracellular cysteine and glutathione concentrations
AU4195899A (en) * 1998-05-21 1999-12-06 Roger Davis Deutsch Patient-controlled lymphocyte method for detecting nutrient deficiency
US7136820B1 (en) * 1999-11-22 2006-11-14 Advanced Medical Instruments Method/process of determining a personal dietary supplement profile and recommending dietary supplements for an individual
US20050070487A1 (en) * 2001-04-24 2005-03-31 Nyce Jonathan W. Composition, formulations and kit for treatment of respiratory and lung disease with non-glucocorticoid steroids and/or ubiquinone and a bronchodilating agent
WO2002085297A2 (en) * 2001-04-24 2002-10-31 East Carolina University Compositions & formulations with a non-glucocorticoid steroid &/or a ubiquinone & kit for treatment of respiratory & lung disease
US6723527B2 (en) 2001-10-26 2004-04-20 Board Of Regents, The University Of Texas System Methods for determining toxicity reversing agents
AU2003269889B2 (en) * 2002-06-17 2007-04-19 Epigenesis Pharmaceuticals, Llc Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compositions thereof
US7405207B2 (en) * 2002-06-17 2008-07-29 Epigenesis Pharmaceuticals, Inc. Nebulizer formulations of dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compositions thereof
US20090274676A1 (en) * 2003-07-31 2009-11-05 Robinson Cynthia B Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a pde-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20090263381A1 (en) * 2003-07-31 2009-10-22 Robinson Cynthia B Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anti-ige antibody for treatment of asthma or chronic obstructive pulmonary disease
US20090285899A1 (en) * 2003-07-31 2009-11-19 Robinson Cynthia B Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a methylxanthine derivative for treatment of asthma or chronic obstructive pulmonary disease
US20090297611A1 (en) * 2003-07-31 2009-12-03 Robinson Cynthia B Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a tyrosine kinase inhibitor, delta opioid receptor antagonist, neurokinin receptor antagonist, or vcam inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20050026883A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20050038004A1 (en) * 2003-07-31 2005-02-17 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
US20050026884A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
US20050026890A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an antihistamine for treatment of asthma or chronic obstructive pulmonary disease
US20050026880A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a cromone for treatment of asthma or chronic obstructive pulmonary disease
US20050085430A1 (en) * 2003-07-31 2005-04-21 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20050026879A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a tyrosine kinase inhibitor, delta opioid receptor antagonist, neurokinin receptor antagonist, or VCAM inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20050043282A1 (en) * 2003-07-31 2005-02-24 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a lipoxygenase inhibitor for treatment of asthma or chronic obstructive pulmonary disease
US20050026882A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
US20090285900A1 (en) * 2003-07-31 2009-11-19 Robinson Cynthia B Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
US20050101545A1 (en) * 2003-07-31 2005-05-12 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
US20050026848A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a methylxanthine derivative for treatment of asthma or chronic obstructive pulmonary disease
US20050026881A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anti-IgE antibody for treatment of asthma or chronic obstructive pulmonary disease
US20050113318A1 (en) * 2003-07-31 2005-05-26 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a beta-agonist bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
EP1824516A4 (en) * 2004-10-29 2008-11-05 Target Discovery Inc GLYCAN ANALYSIS WITH DEUTERATED GLUCOSE
WO2006127761A1 (en) * 2005-05-26 2006-11-30 Pediatrix Medical Group, Inc. Nutrition formulations and methods of providing nutrition formulations
US7838526B2 (en) * 2005-08-05 2010-11-23 Esther Baldinger Method of treating neurological disorders
CN101780083B (zh) * 2009-01-16 2012-01-25 海南四环医药有限公司 一种亚叶酸钙与苯丙氨酸的组合物及其制备方法
US20100210582A1 (en) * 2009-02-18 2010-08-19 Stewart Kendal L Method and composition for treating patients with a high risk of developing neuro-immune disorders or developmental delays, identified through the utilization of low homocysteine or its precursors/metabolites, as the predictor of such risk
LT2837680T (lt) 2011-07-01 2020-07-10 Amgen Inc. Žinduolių ląstelių kultūra
MX2020011614A (es) 2018-05-01 2020-12-09 Amgen Inc Anticuerpos con perfiles de glicanos modulados.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US309985A (en) * 1884-12-30 Milk-can
US3128228A (en) * 1960-03-04 1964-04-07 Ustav Ser A Ockovacich Latek Tissue culture medium
US4282326A (en) * 1978-10-12 1981-08-04 Jeanne Moldenhauer Cell culture medium supplement
US4302437A (en) * 1979-08-30 1981-11-24 Victor Herbert Mitogen stimulated lymphocyte transformation
JPS57194787A (en) * 1981-05-28 1982-11-30 Ajinomoto Co Inc Culture medium for animal cell

Also Published As

Publication number Publication date
FI77470C (fi) 1989-03-10
PT76808A (en) 1983-07-01
GB2124366B (en) 1986-11-12
SG57287G (en) 1987-09-18
AU560934B2 (en) 1987-04-30
IL68873A (en) 1987-03-31
AU1536483A (en) 1983-12-08
US4499064A (en) 1985-02-12
NZ204471A (en) 1987-08-31
FI77470B (fi) 1988-11-30
KR840005012A (ko) 1984-11-03
DK254383A (da) 1983-12-04
NO164252B (no) 1990-06-05
HK90188A (en) 1988-11-18
IL68873A0 (en) 1983-10-31
ES8405953A1 (es) 1984-06-16
FI832005A0 (fi) 1983-06-03
IE831322L (en) 1983-12-03
GB8315287D0 (en) 1983-07-06
NO831985L (no) 1983-12-05
DK254383D0 (da) 1983-06-03
KR890000729B1 (ko) 1989-03-30
EP0096560B1 (en) 1987-05-06
IE55162B1 (en) 1990-06-20
EP0096560A1 (en) 1983-12-21
FI832005L (fi) 1983-12-04
CA1199883A (en) 1986-01-28
ES522980A0 (es) 1984-06-16
DE3371362D1 (en) 1987-06-11
DK172418B1 (da) 1998-06-02
MX161244A (es) 1990-08-24
GB2124366A (en) 1984-02-15

Similar Documents

Publication Publication Date Title
NO164252C (no) Celledyrkningsmedium og anvendelse derav ved bestemmelse av naerings- og biokjemiske tilstander hos lymfocytter.
DE3274884D1 (en) Culture medium and its use
NO171719C (no) Fluidoverfoering i aapen sjoe
ES518328A0 (es) Perfeccionamientos en la fabricacion de tarjetas de identificacion y similares.
EP0138833A4 (en) Methods for determining the viability of cells and device for their implementation.
DK240285D0 (da) Fremgangsmaade til paavisning af polymorfe restriktionssteder samt kittil brug ved fremgangsmaaden
MX9203117A (es) Benzotiofenos antiestrogenicos y antiandrogenicos.
ES516383A0 (es) "bandeja ensamblable y apilable y aparato correspondiente para su montaje".
DE3676558D1 (de) Fluidumverteilung bei mehrfachleitungen.
NO812247L (no) Interferoner og fremgangsmaate ved fremstilling derav
DE3382390D1 (de) Zellinien und ihre verwendung in der herstellung von proteinen.
DK324882A (da) Polyamider og funktionelle vaesker indeholdende disse
MX154390A (es) Mejoras en celda galvanica
ES557662A0 (es) Un metodo y su correspondiente dispositivo para la determinacion de anticuerpos en liquidos biologicos.
DE3869733D1 (de) Durchflusszelle.
DK147077C (da) Celledyrkningsbeholder
DE3380125D1 (en) Assay for the free portion of substances in biological fluids
JPS56102790A (en) Stabilization of peroxydizing enzyme in medium based on serum protein
NO853960L (no) Oljelagrings- og overfoeringsanlegg.
DE3280078D1 (de) Bitleitungsbetriebene translineare speicherzelle.
IT1129100B (it) Reggispinta autocentrante per in nesti e frizioni
DE3369386D1 (en) Assay for the free portion of substances in biological fluids
NO157476C (no) Anordning ved flytelegeme for bruk ved borehulls-seismikkmaalinger.
NO821376L (no) Dyrkningsmedium.
ZA805898B (en) Assay for the free portion of substances in biological fluids

Legal Events

Date Code Title Description
MK1K Patent expired

Free format text: EXPIRED IN JUNE 2003